Clinical Trial
doi: 10.1054/ijom.2002.0276.Idiopathic dysgeusia; an open trial of alpha lipoic acid (ALA) therapy
Affiliations
- PMID:12521319
- DOI: 10.1054/ijom.2002.0276
Item in Clipboard
Clinical Trial
Idiopathic dysgeusia; an open trial of alpha lipoic acid (ALA) therapy
F Femiano et al. Int J Oral Maxillofac Surg.2002 Dec.
Display options
Format
Display options
Format
Abstract
We selected two homogenous groups, each of 22 patients with idiopathic dysgeusia, an altered perception of taste, matched for age and sex, for an open trial of alpha lipoic acid compared with placebo. The 22 patients in the study group were treated with alpha lipoic acid for 2 months. The 22 patients in the control group were treated for 2 months with carboxymethylcellulose. The latter group was then treated with alpha lipoic acid for 2 months. The results showed significant symptomatic improvements compared with placebo, in both groups of patients with dysgeusia treated with alpha lipoic acid, suggesting that idiopathic dysgeusia may be a neuropathy comparable to the burning mouth syndrome.
Similar articles
- Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology.Femiano F, Gombos F, Scully C, Busciolano M, De Luca P.Femiano F, et al.Oral Dis. 2000 Sep;6(5):274-7. doi: 10.1111/j.1601-0825.2000.tb00138.x.Oral Dis. 2000.PMID:11002408Clinical Trial.
- Alpha-lipoic acid treatment of 31 patients with sore, burning mouth.Steele JC, Bruce AJ, Drage LA, Rogers RS 3rd.Steele JC, et al.Oral Dis. 2008 Sep;14(6):529-32. doi: 10.1111/j.1601-0825.2007.01414.x. Epub 2008 Feb 10.Oral Dis. 2008.PMID:18266840
- Burning mouth syndrome: the efficacy of lipoic acid on subgroups.Femiano F, Gombos F, Scully C.Femiano F, et al.J Eur Acad Dermatol Venereol. 2004 Nov;18(6):676-8. doi: 10.1111/j.1468-3083.2004.01049.x.J Eur Acad Dermatol Venereol. 2004.PMID:15482293
- Burning mouth syndrome: a systematic review of treatments.Liu YF, Kim Y, Yoo T, Han P, Inman JC.Liu YF, et al.Oral Dis. 2018 Apr;24(3):325-334. doi: 10.1111/odi.12660. Epub 2017 Mar 30.Oral Dis. 2018.PMID:28247977Review.
- Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.Ziegler D, Gries FA.Ziegler D, et al.Diabetes. 1997 Sep;46 Suppl 2:S62-6. doi: 10.2337/diab.46.2.s62.Diabetes. 1997.PMID:9285502Review.
Cited by
- Interventions for managing taste disturbances.Kumbargere Nagraj S, George RP, Shetty N, Levenson D, Ferraiolo DM, Shrestha A.Kumbargere Nagraj S, et al.Cochrane Database Syst Rev. 2017 Dec 20;12(12):CD010470. doi: 10.1002/14651858.CD010470.pub3.Cochrane Database Syst Rev. 2017.PMID:29260510Free PMC article.Review.
- Effect of γ-Cyclodextrin Inclusion Complex on the Absorption of R-α-Lipoic Acid in Rats.Uchida R, Iwamoto K, Nagayama S, Miyajima A, Okamoto H, Ikuta N, Fukumi H, Terao K, Hirota T.Uchida R, et al.Int J Mol Sci. 2015 May 4;16(5):10105-20. doi: 10.3390/ijms160510105.Int J Mol Sci. 2015.PMID:25946345Free PMC article.
- How to Manage Taste Disorders.Hsieh JW, Daskalou D, Macario S, Voruz F, Landis BN.Hsieh JW, et al.Curr Otorhinolaryngol Rep. 2022;10(4):385-392. doi: 10.1007/s40136-022-00428-z. Epub 2022 Sep 21.Curr Otorhinolaryngol Rep. 2022.PMID:36158900Free PMC article.Review.
- Oral adverse effects of drugs: Taste disorders.Rademacher WMH, Aziz Y, Hielema A, Cheung KC, de Lange J, Vissink A, Rozema FR.Rademacher WMH, et al.Oral Dis. 2020 Jan;26(1):213-223. doi: 10.1111/odi.13199. Epub 2019 Nov 11.Oral Dis. 2020.PMID:31532870Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical